Literature DB >> 31966823

DKK1 maintained cancer stem-like properties of esophageal carcinoma cells via ALDH1A1/SOX2 axis.

Zhibin Lu1, Cunrong Zhou1, Jiaojiao Hu2, Lei Xiong3, Zhuangzhuang Cong3, Yi Shen3.   

Abstract

Dickkopf-1 (DKK1) has been reported as a key regulator in the progression of esophageal carcinoma (EC). Aldehyde dehydrogenase 1A1 (ALDH1A1) possesses stem-like properties and predicts patient outcome in several cancers. However, whether DKK1 regulates cancer stem-like properties of EC cells through modulating ALDH1A1 activity remains unclear. In this study, we found that DKK1 knockdown significantly reduced cell proliferation, colony formation and CK18 expression. Additionally, knockdown of DKK1 also decreased the expression of ALDH1A1 involved in a c-Jun-dependent manner through a pathway consisting of p38/JNK/c-Jun pathway. Furthermore, the downregulation of ALDH1A1 gene expression in Eca109 resulted in decreased expression of cancer stem cell-associated markers SOX2, Bmi1 and vimentin. Therefore, our results demonstrated that DKK1 maintained cancer stem-like properties of EC cells via ALDH1A1/SOX2 axis. DKK1 may act as a therapeutic target for the treatment of EC. IJCEP
Copyright © 2017.

Entities:  

Keywords:  ALDH1A1; DKK1; SOX2; c-Jun; esophageal carcinoma

Year:  2017        PMID: 31966823      PMCID: PMC6965918     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  7 in total

Review 1.  Long Non-coding RNAs With In Vitro and In Vivo Efficacy in Preclinical Models of Esophageal Squamous Cell Carcinoma Which Act by a Non-microRNA Sponging Mechanism.

Authors:  Ulrich H Weidle; Fabian Birzele
Journal:  Cancer Genomics Proteomics       Date:  2022 Jul-Aug       Impact factor: 3.395

Review 2.  ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism.

Authors:  Hanxun Yue; Zenan Hu; Rui Hu; Zeying Guo; Ya Zheng; Yuping Wang; Yongning Zhou
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

Review 3.  Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy.

Authors:  Alexander Kabakov; Anna Yakimova; Olga Matchuk
Journal:  Cells       Date:  2020-04-06       Impact factor: 6.600

4.  Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of Dickkopf-1 (DKK1).

Authors:  Shuang Gao; Ye Jin; Hongmei Zhang
Journal:  Front Genet       Date:  2021-11-24       Impact factor: 4.599

5.  RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis.

Authors:  Zhiying Yue; Xin Niu; Zengjin Yuan; Qin Qin; Wenhao Jiang; Liang He; Jingduo Gao; Yi Ding; Yanxi Liu; Ziwei Xu; Zhenxi Li; Zhengfeng Yang; Rong Li; Xiwen Xue; Yankun Gao; Fei Yue; Xiang H-F Zhang; Guohong Hu; Yi Wang; Yi Li; Geng Chen; Stefan Siwko; Alison Gartland; Ning Wang; Jianru Xiao; Mingyao Liu; Jian Luo
Journal:  J Clin Invest       Date:  2022-01-18       Impact factor: 19.456

Review 6.  Dickkopf-1: A Promising Target for Cancer Immunotherapy.

Authors:  Hang Yin Chu; Zihao Chen; Luyao Wang; Zong-Kang Zhang; Xinhuan Tan; Shuangshuang Liu; Bao-Ting Zhang; Aiping Lu; Yuanyuan Yu; Ge Zhang
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

7.  Morpholino-driven blockade of Dkk-1 in osteosarcoma inhibits bone damage and tumour expansion by multiple mechanisms.

Authors:  Simin Pan; Michael Cesarek; Carla Godoy; Cynthia M Co; Catherine Schindler; Kelbi Padilla; Andrew Haskell; Heather Barreda; Christopher Story; Roy Poole; Alan Dabney; Carl A Gregory
Journal:  Br J Cancer       Date:  2022-03-11       Impact factor: 9.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.